WARF Ventures Portfolio

WARF Venture Startup Portfolio Stats

WARF holds equity in more than 30 of these companies, and more than 50 are located in Wisconsin. Some of these companies have achieved IPO status as publicly traded companies and have been acquired by large, well-established companies, such as Roche, Johnson & Johnson and Hologic.

Interested in learning more about one of these companies? Contact [email protected]

ACTIVE STARTUPS

AIQ Solutions Inc.

Artificial intelligence to evaluate treatment response in complex diseases

Atrility Medical

Device to improve atrial arrhythmia diagnosis

BrainXell

Human neural cells for discovery and therapy

C-Motive Technologies

The world's lightest, most powerful non-rare earth electric motors and non-contact power transfer devices

Co-D Therapeutics Inc.

Innovative cancer drug development

DataChat Inc.

Conversational intelligence platform

Elephas

Developing an imaging platform technology to assess how live tumor cells respond to cancer therapies

Elucent Medical

Innovative surgical navigation tool for tumor excision

FitStack

Shrinks application attack surfaces to optimize cloud container environments and reduce ongoing cloud costs

FluGen Inc.

Influenza vaccines

Galilei BioSciences Inc.

Developing sirtuin drugs

Gregor Diagnostics Inc.

Screening and determination of the aggressiveness of prostate cancer

Hubble Therapeutics LLC

Gene therapy for pediatric patients with a retinal blinding disease

Imbed Biosciences

Multifunctional polymeric nanofilms technology that provides cutting edge solutions in wound healing

Immuto Scientific

Contract research organization providing analytical research services for drug discovery

Infleqtion

Building an ecosystem of quantum technologies & commercial products, driving the industry towards tomorrow

Innervace

Regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury

Invenra

Developing versatile drug discovery platforms and optimizing therapies

Isomark

Non-invasive patented platform technology used to monitor health status by measuring and analyzing isotopic biomarkers through exhaled breath

Leo Cancer Care/Asto CT

Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes through upright positioning

Lynx Biosciences

Personalized cancer treatments to patients

Madison Vaccines Inc.

DNA vaccines intended to treat prostate cancer at crucial stages in the disease

OnLume

Medical device for precise fluorescence image-guided surgery

PROMISS Diagnostics Inc.

Globally accessible, non-invasive and precise diagnostic test for ovarian cancer

Pyran

Produces a renewable, sustainable and cost-effective alternative to an oil-based chemical (1,5-pentanediol) found in everyday materials including paint, nylon and other plastics

Quiver Quantitative

Gathers alternative stock data from across the internet and aggregates it in an easy-to-use web dashboard and mobile app designed for non-professional investors.